Using tramadol to measure CYP2D6 metabolism in critically ill adults

被引：0
|
作者：
Katie Lane
John J. Dixon
Denise McKeown
Atholl Johnston
Ron H. N. van Schaik
Marianne van Fessem
Iain A. M. MacPhee
Barbara J. Philips
机构：
[1] St George’s,Division of Clinical Sciences: Intensive Care
[2] University of London,General Intensive Care Unit
[3] St George’s,Analytical Services International Ltd
[4] University of London,Department of Clinical Chemistry
[5] St George’s,Division of Clinical Sciences: Renal Medicine
[6] University of London,undefined
[7] Erasmus University Medical Centre,undefined
[8] St George’s,undefined
[9] University of London,undefined
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
Tramadol; Acute Kidney Injury; Kidney Disease Improve Global Outcome; Hepatic Drug Metabolism; CYP2D6 Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1177 / 1178
页数：1
相关论文
共 50 条
  • [31] Relationship of CYP2D6 status and toremifene metabolism
    Kim, J.
    Dalton, J. T.
    Veverka, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] CYP2D6 is primarily responsible for the metabolism of clomiphene
    Ghobadi, Cyrus
    Gregory, Anne
    Crewe, H. Kim
    Rostami-Hodjegan, Amin
    Lennard, Martin S.
    DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (02) : 101 - 105
  • [33] Enantioselective metabolism of primaquine by human CYP2D6
    Pius S Fasinu
    Babu L Tekwani
    NP Dhammika Nanayakkara
    Bharathi Avula
    HMT Bandara Herath
    Yan-Hong Wang
    Vijender R Adelli
    Mahmoud A Elsohly
    Shabana I Khan
    Ikhlas A Khan
    Brandon S Pybus
    Sean R Marcsisin
    Gregory A Reichard
    James D McChesney
    Larry A Walker
    Malaria Journal, 13
  • [34] Enantioselective metabolism of primaquine by human CYP2D6
    Fasinu, Pius S.
    Tekwani, Babu L.
    Nanayakkara, N. P. Dhammika
    Avula, Bharathi
    Herath, H. M. T. Bandara
    Wang, Yan-Hong
    Adelli, Vijender R.
    Elsohly, Mahmoud A.
    Khan, Shabana I.
    Khan, Ikhlas A.
    Pybus, Brandon S.
    Marcsisin, Sean R.
    Reichard, Gregory A.
    McChesney, James D.
    Walker, Larry A.
    MALARIA JOURNAL, 2014, 13
  • [35] A novel CYP2D6 scoring system for the prediction of CYP2D6 activity: Application to tamoxifen metabolism.
    Borges, S.
    Li, L.
    Robarge, J.
    Nguyen, A.
    Azzouz, F.
    Desta, Z.
    Skaar, T.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S67 - S67
  • [36] Olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia
    Iwahashi, K
    ACTA NEUROPSYCHIATRICA, 2004, 16 (04) : 229 - 230
  • [37] Using tramadol to monitor hepatic drug metabolism in the critically ill
    K Lane
    JJ Dixon
    D McKeown
    A Johnston
    I MacPhee
    BJ Philips
    Critical Care, 16 (Suppl 1):
  • [38] In vitro comparative analysis of metabolic capabilities and inhibitory profiles of selected CYP2D6 alleles on tramadol metabolism
    Nahid, Noor Ahmed
    Kanumuri, Siva Rama Raju
    Sharma, Abhisheak
    Wang, Danxin
    Johnson, Julie A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (02):
  • [39] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [40] TRAMADOL EFFICACY AND CYP2D6 POLYMORPHISM IN PATIENTS AFTER ARTHROSCOPIC SURGERY
    Slanar, O.
    Dupal, P.
    Perlik, K. F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 75 - 76
12345